Covered recipient · General Payments record
KENZIE LYN OBERDORF
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$800.38
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $692.08 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $188.20 | 7 |
| Amgen Inc. | $162.46 | 12 |
| ABBVIE INC. | $64.65 | 3 |
| Lilly USA, LLC | $53.43 | 3 |
| GlaxoSmithKline, LLC. | $49.89 | 2 |
| Phathom Pharmaceuticals, Inc. | $47.73 | 2 |
| PFIZER INC. | $41.38 | 2 |
| Acerta Pharma LLC | $29.04 | 2 |
| Sumitomo Pharma America, Inc. | $22.60 | 1 |
| DEXCOM, INC. | $16.61 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.30 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107754464 | CMS |
| ABBVIE INC. | $14.40 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107754466 | CMS |
| ABBVIE INC. | $15.95 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107754468 | CMS |
| Amgen Inc. | $18.36 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643763 | CMS |
| Amgen Inc. | $16.74 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117341658 | CMS |
| Amgen Inc. | $20.28 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643765 | CMS |
| Amgen Inc. | $8.34 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643767 | CMS |
| Amgen Inc. | $19.38 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643769 | CMS |
| Amgen Inc. | $5.65 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117341660 | CMS |
| Amgen Inc. | $21.09 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643771 | CMS |
| Amgen Inc. | $5.73 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643773 | CMS |
| Amgen Inc. | $7.98 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643775 | CMS |
| Amgen Inc. | $15.07 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117341662 | CMS |
| Amgen Inc. | $6.70 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643777 | CMS |
| Amgen Inc. | $17.14 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117643779 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.33 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105466167 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.71 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104526970 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.09 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117947621 | CMS |
| Dexcom, Inc. | $16.61 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153371575 | CMS |
| GlaxoSmithKline, LLC. | $25.06 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116475480 | CMS |
| GlaxoSmithKline, LLC. | $24.83 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115912966 | CMS |
| Lilly USA, LLC | $18.42 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135760640 | CMS |
| Lilly USA, LLC | $16.02 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135775554 | CMS |
| Lilly USA, LLC | $18.99 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135770002 | CMS |
| Novo Nordisk Inc | $10.52 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100494905 | CMS |
| Novo Nordisk Inc | $21.99 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100563119 | CMS |
| Novo Nordisk Inc | $12.00 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100458750 | CMS |
| Novo Nordisk Inc | $22.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100540276 | CMS |
| Novo Nordisk Inc | $20.31 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100594727 | CMS |
| Novo Nordisk Inc | $86.24 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100337631 | CMS |
| Novo Nordisk Inc | $15.14 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100580782 | CMS |
| PFIZER INC. | $17.41 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131376315 | CMS |
| PFIZER INC. | $23.97 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131771709 | CMS |
| Phathom Pharmaceuticals, Inc. | $23.33 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151193631 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.40 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151193633 | CMS |
| Sumitomo Pharma America, Inc. | $22.60 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148985160 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.